- $6.73bn
- $6.28bn
- $22.29m
Buzz Us Stocks On The Move: Tesla, Warner Bros Discovery, Netflix
U.S. STOCKS ON THE MOVE-Micron, NextEra Energy, Ocular Therapeutix
Arcellx surges after promising data from mid-stage cancer therapy trial
Clinical-stage biotech firm Arcellx's Q3 revenue drops, misses expectations
Biotech firm Arcellx's Q2 revenue misses estimates
Brief: Arcellx Appoints Andrew Galligan And Kristin Myers To Its Board Of Directors
U.S. STOCKS ON THE MOVE-Apollo, Hershey, RH
U.S. STOCKS ON THE MOVE-Warner Bros, Seres Therapeutics, Enterprise Bancorp
U.S. STOCKS ON THE MOVE-Tesla, Nvidia, Palantir
Arcellx climbs on positive trial data for blood cancer cell therapy
Brief: Arcellx Says Three Deaths Due To Treatment-Emergent Adverse Events In Anito-Cel Study
Brief: Rami Elghandour Reports 5.0% Stake In Arcellx Inc As Of November 3, 2024- SEC Filing
U.S. RESEARCH ROUNDUP-Bath & Body Works, Datadog, Savers value Village
U.S. RESEARCH ROUNDUP-Apollo, Booking Holdings, Portillos
U.S. STOCKS ON THE MOVE-Wave Life Sciences, Dominion Energy, Voyager Therapeutics
Arcellx rises as Guggenheim lifts PT, reiterates 'buy' rating
U.S. RESEARCH ROUNDUP- Autozone, Costco Wholesale, Walmart
U.S. RESEARCH ROUNDUP- Akoya Biosciences, Boston Beer Company, Victory Capital Holdings
Brief: Gilead Sciences Reports 12.9% Passive Stake In Arcellx As Of Dec 28